pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,899 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
  • phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›AVAILABLEphase readoutNCT05041036: Individual Patient Compassionate Use of Nirogacestat

    Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany. Phase: . Conditions: Desmoid Tumor, NOTCH Gene Mutation Positive Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03012971: Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery

    Sponsor: Peking University First Hospital. Phase: NA. Conditions: Elderly, Surgery, Analgesia, Dexmedetomidine, Long-term Outcome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07444671: Impact of Time-restricted Eating on Sleep, Glucose and Insulin Sensitivity

    Sponsor: Colorado State University. Phase: NA. Conditions: Time Restricted Eating

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07243171: A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

    Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.. Phase: PHASE1. Conditions: Overweight and/or Obesity, Weight Management

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07616271: Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and Enhancing Efficacy of CAR-T Cell Therapy

    Sponsor: Tongji Hospital. Phase: PHASE2. Conditions: Patients With Large B-cell Lymphoma Receiving CAR-T Cell Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07352644: Factors Affecting Attachment Loss in Clear Aligner Treatment

    Sponsor: Bezmialem Vakif University. Phase: NA. Conditions: Malocclusion, Crowded Teeth, Attachment

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04145141: National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Hepatocellular Carcinoma, Liver Cancer, Cholangiocarcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06943573: Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

    Sponsor: Lakshmi N Yatham. Phase: PHASE3. Conditions: Bipolar II Depression

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07455669: Effects of Microgalvanic Current on Body Satisfaction and Quality of Life in Women With Striae Alba

    Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri. Phase: NA. Conditions: White Stretch Marks (Striae Albae)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04248283: Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

    Sponsor: Uromedica. Phase: NA. Conditions: Urinary Incontinence, Urinary Incontinence,Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06708754: Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Radiation Lymphedema, Radiation Fibrosis, Head and Neck Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06467305: Speech Motor Learning and Retention (Aim 1)

    Sponsor: Yale University. Phase: NA. Conditions: Speech

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06609005: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

    Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.. Phase: PHASE1. Conditions: Advanced Metastatic Castration Resistant Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07638605: Sensory and Behavioral Sleep Training

    Sponsor: Atlas University. Phase: NA. Conditions: Sleep Disorder (Disorder)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05874466: SenseToKnow Autism Screening Device Validation Study

    Sponsor: Duke University. Phase: . Conditions: Autism, Autism Spectrum Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07310394: LLM-Generated Lay Summaries for Brain MRI Reports

    Sponsor: University Hospital, Lille. Phase: NA. Conditions: Headache

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04562194: NeVa ONE Registry Study

    Sponsor: Vesalio. Phase: NA. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07528066: Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

    Sponsor: Shanghai Chest Hospital. Phase: . Conditions: Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06274866: Effects Of A Home Based Exercise Program Following Total Hip Arthroplasty

    Sponsor: Halic University. Phase: NA. Conditions: PHYSİOTHERAPY

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07561866: Prognostic Impact of Diabetes and Weight Variability in Telemonitored Heart Failure

    Sponsor: Satelia. Phase: . Conditions: Chronic Heart Failure, Type 2 Diabetes, Diabetes (DM)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06831266: Effects of Exercise Prediabetic Individuals

    Sponsor: Eastern Mediterranean University. Phase: NA. Conditions: Prediabetes / Type 2 Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06218056: Cannabidiol for Reducing Cigarette Use

    Sponsor: University of California, Los Angeles. Phase: PHASE2. Conditions: Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07146451: 6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Children Born to Mothers Enrolled in the TOCOPROM Trial

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07051031: COVID-19 Reactogenicity

    Sponsor: Marcel Curlin. Phase: PHASE4. Conditions: COVID-19

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06329531: Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Cancer, Occupational Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02360202: Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid

    Sponsor: University Hospital, Rouen. Phase: PHASE4. Conditions: Bullous Pemphigoid

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07603453: Performance of Clinical Metagenomics in Stool and Urine Samples for Unexplained Diseases Diagnostic and Emerging Diseases Surveillance in Immunocompromised Patients

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Primary or Secondary Immune Deficiency Including Immunosuppressive Therapy, Chemotherapy, HIV Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07461753: Development, Validation, and Assessment of the Diagnostic Accuracy of a Questionnaire for Periodontitis Screening

    Sponsor: Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy. Phase: . Conditions: Periodontal Diseases, Periodontitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05861453: Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

    Sponsor: Afimmune. Phase: PHASE2. Conditions: Sickle Cell Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05220137: Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Stress Disorders, Post-Traumatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05226637: Does ESWT With BoNTA Treatment Improve Outcomes When Compared to Standard Management for Upper Limb Spasticity Patient.

    Sponsor: University of Alberta. Phase: NA. Conditions: Spasticity, Muscle

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05718895: A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors

    Sponsor: Antengene Biologics Limited. Phase: PHASE1. Conditions: Advanced/Metastatic Solid Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04113395: Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium

    Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Meningioma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04933539: Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06705439: A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)

    Sponsor: Neuro Event Labs Inc.. Phase: . Conditions: Epilepsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07449377: Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Acute Heart Failure (AHF)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07200401: Exploring if Patients Can Safely and Easily Swab Their Own Surgical Wounds at Home

    Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: NA. Conditions: Cardiac Surgery, Infection, Soft Tissue, Wound Healing, Swabs, Self Management

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506681: IMAT Quality in Aging

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06184581: Lithium Versus Lamotrigine in Bipolar Disorder, Type II

    Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: PHASE4. Conditions: Bipolar II Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

    Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Atrial Fibrillation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07408830: VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High Grade Bladder Tumors

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: High-Grade Early-Stage Bladder Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07603830: Personality Type, Leadership Style and Training Needs Among Nurses

    Sponsor: Sri Ramachandra Institute of Higher Education and Research. Phase: . Conditions: Personality Type, Leadership Style, Training Status

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06479330: Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate

    Sponsor: Mondelēz International, Inc.. Phase: NA. Conditions: Gastrointestinal Tolerance, Healthy Population

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03991728: Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry

    Sponsor: AO Innovation Translation Center. Phase: . Conditions: Temporomandibular Joint Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05691465: Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Small Cell Neuroendocrine Carcinoma, Stage IVB Prostate Cancer AJCC v8

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07119567: Impact of Cocaine Use and Withdrawal on Sleep

    Sponsor: Hôpital le Vinatier. Phase: . Conditions: Cocaine Use Disorder

    full page →ctgov ↗
    ›NO_LONGER_AVAILABLEphase readoutNCT05779267: NRX-101 Expanded Access

    Sponsor: NeuroRx, Inc.. Phase: . Conditions: Bipolar Depression, Bipolar Affective Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07621900: Effects of Lokomat Training on Dynamic Postural Stability in Incomplete Spinal Cord Injury

    Sponsor: I.R.C.C.S. Fondazione Santa Lucia. Phase: NA. Conditions: Spinal Cord Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07495800: Weight and BMI Patterns in Biological Based IBD Patients and Its Finacial Impact

    Sponsor: Assiut University. Phase: . Conditions: Inflammatory Bowel Diseases Weight Changes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04911400: Effects of Class III Elastics on Stability of Orthopaedic Class III Correction

    Sponsor: Sydney Local Health District. Phase: NA. Conditions: Class III Malocclusion, Underbite

    full page →ctgov ↗
    ← prev
    page 73 of 98
    next →